It has been demonstrated that supplementation of critically ill trauma patients with probiotic bacteria reduces the inflammatory cytokine response and attenuates the increase in intestinal permeability observed in such patients, 29 while animal work has shown that probiotics can prevent the inflammation-induced epithelial barrier defect associated with loss of tight junction proteins.
Numerous other clinical conditions have been shown to contribute to epithelial barrier defects and leakiness. Conditions such as sepsis, severe acute pancreatitis, jaundice and inflammatory bowel disease are associated with a generalised hyper-permeability of the small and large intestines. Critically ill patients probably develop intestinal barrier dysfunction with enhanced permeability as well as disordered gastrointestinal motility via different mechanisms, and most likely via the cumulative effect of various mechanisms combined. Whatever the mechanism, gut pathophysiology of various kinds seems to be not only an effect of, but also a contributor to, critical illness.
Bowel dysfunction is associated with increased morbidity and poor clinical outcomes, including increased mortality. In broad terms, there are two main inter-related clinical effects of gut dysfunction in ICU, the first being on nutrition and the second on infection risk. Impaired gut function significantly compromises delivery of enteral nutrition. Consequently, obsessive tuning of nutritional support to the gastric residual signal may unduly hinder enteral feeding, while not actually serving as a proxy for poor gastric emptying.
Register for a free account
Nevertheless, gastric residual volume, as possibly the single most widely used crude indicator of retained gastric contents, does correlate with low energy intake. It has been shown in burns patients, however, that initiation of enteral feed as part of acute resuscitation measures within 6 hours of injury helps to prevent delayed gastric emptying. Small bowel factors play a role in diminished absorption as well, because nutrient delivery directly into the small intestine is also associated with lower absorption in the critically ill. Diarrhoea with nutrient malabsorption can also be a result of small intestinal bacterial overgrowth associated with altered bowel flora populations, and poor mucosal repair.
Diarrhoea that impedes enteral feeding may lead to a perpetuating feed-associated gastrointestinal symptom cycle, because enteral nutrients are necessary for intact mucosal function and vice versa. Nutrition deficits in critically ill patients are associated with worse clinical outcomes, including increased risk of infectious complications which at least in part are linked to gastrointestinal dysfunction.
Proposed infectious consequences of disordered gut function include aspiration with an associated predisposition to ventilator-associated pneumonia, and gut-derived nosocomial sepsis. Aspiration of feed in the critically ill patient is certainly one of the most anxiety-provoking morbidities associated with enteral nutrition support. Since it is associated with poor respiratory function and nosocomial pneumonia, it is also the point where goals for provision of adequate nutrition and goals for prevention of septic complications of ICU stay intersect.
While the sensitivity and specificity are fairly poor, a thread of association between high gastric residual volumes and tracheobronchial aspiration of stomach contents has been shown. While gastric residual volumes alone are not associated with pneumonia risk, feed intolerance defined as a combination of high retained gastric volumes together with vomiting is significantly associated with ICU-acquired pneumonia, as well as longer ICU stays and increased mortality.
Ironically, inappropriately low gastric residual volume cut-offs to define enteral feeding protocols have been shown to result in unnecessary enteral feed stoppages, a phenomenon that was correlated with an increased incidence of infection and nosocomial pneumonia compared with patients who received significantly higher enteral formula volumes. Another theoretical concern is that poorly synchronised gastrointestinal motor activity in very ill patients may impair the elimination of intestinal contents and place critically ill patients at risk of prolonged exposure to antigenic and microbiological agents, which remain in contact with the compromised intestinal barrier.
The clinical significance of increased gut permeability in sepsis risk is not entirely known. Original bacterial translocation theories, never demonstrated convincingly in humans, have been all but refuted. However, recent in vivo evidence indicates that infectious complications and mortality were significantly increased in critically ill patients with SIRS who had abnormally low obligate commensal floral counts within the intestine. The currently understood mechanisms involved include the abilities of lethal pathogenic bacteria found in excess in the unbalanced gut floral environments of the critically ill to transfer their gene products into intestinal epithelial cells adjacent to the immune system, to produce and exist with biofilms resistant to antibiotic penetration, and the initiation of pathogen quorum sensing by molecular mediators in shocked and reperfusion-injured gut tissue.
Acute Skeletal Muscle Wasting in Critical Illness
One of the difficulties in investigating gastrointestinal dysfunction in ICU patients is the lack of consistent definitions for the various aspects that are incorporated in the concept of gut dysfunction, making comparison of research from different centres problematic. Clarification is needed. In , a Working Group on Abdominal Problems of the European Society of Intensive Care Medicine convened to compile an evidence- and expert opinion-based, but as yet unvalidated, list of definitions and a grading system for gastrointestinal dysfunction in the critically ill.
The intention is that the terminology be applicable in both clinical and research applications, and possibly validated as part of organ failure scoring in the future. The report does, however, not address gut barrier or immunological functions, or those under neuroendocrine control — possibly the most challenging aspects to pin to objectively evaluable definitions. Measurement of circulating mediators such as intestinal fatty acid binding protein I-FABP and citrulline may fill this gap, as they are validated indicators of enterocyte mass, villous atrophy and permeability.
Although a useful start in creating consensus on symptom definition, the weakness of the report of the Working Group on Abdominal Problems is that it is not based on a unifying model of the pathophysiology of gut dysfunction in the critically ill. Researchers from the University of Washington 44 have proposed a theory that attempts to bring together the various apparently disparate and ever-changing models of critical illness-associated gut dysfunction by proposing a complex paradigm wherein the derangements of the different elements of the gastrointestinal organ interact with each other.
Their paradigm attempts to incorporate all of the numerous valid ways of understanding the interrelationship between gut dysfunction and critical illness. Gut function in ICU patients is of clinical interest for a number of reasons. Dysfunction of the gut occurs so commonly in severely ill patients that it affects daily management of the critically ill.
Data indicate that the disordered gastrointestinal function seen in the critically ill incorporates profound abnormalities in gut motor function, loss of barrier integrity and distortions in commensal flora populations. Mechanisms implicated in these functional derangements include inflammatory, myoelectrical and neuroendocrine processes as well as numerous clinical conditions and treatment approaches.
There is currently no complete, unified pathophysiological model of the phenomenon, but cross-disciplinary research opportunities exist both to clarify the mechanisms and also to develop treatments. Does enteral nutrition compared to parenteral nutrition result in better outcomes in critically ill adult patients?
A systematic review of the literature. Nutrition ;20 10 The effect of intra-abdominal hypertension on gastrointestinal function. South African Journal of Critical Care ;27 1 Gastrointestinal symptoms in intensive care patients. Acta Anaesthesiol Scand ; Montejo JC. Crit Care Med ; Multicenter, prospective, randomized, single-blind study comparing the efficacy and gastrointestinal complications of early jejunal feeding with early gastric feeding in critically ill patients.
Crit Care Med ; 30 4 The impact of admission diagnosis on gastric emptying in critically ill patients. Critical Care ;11 1 :R Diminished functional association between proximal and distal gastric motility in critically ill patients. Intensive Care Med ;34 7 Small intestinal motor patterns in critically ill patients after major abdominal surgery.
- How To Start - Driveway Sealing Seal Coating Service - Sample Business Plan Template.
- ORIENTACIÓN EDUCATIVA (MANUALES Y OBRAS DE REFERENCIA) (Spanish Edition).
- Land Where I Flee.
- Archives of Critical Care Medicine.
Am J Gastroenterol ; Determining small intestinal transit time and pathomorphology in critically ill patients using video capsule technology. Intensive Care Med ; Duerkson DR. Stress-related mucosal disease in critically ill patients. Best Prac Res Clin Gastroenterol ; Certain sedatives are also known to affect hormonal status. They showed a significant etomidate-induced depression of adrenal function that led to withdrawal of its use for medium- to long-term sedation in intensive care.
Etomidate is, however, still frequently used as an induction agent for anaesthesia because of its cardiovascular stability. Unfortunately, this practice continues despite the fact that Absalom et al. Other drugs are known to affect hormone levels. Low-dose dopamine, which was a popular and subsequently disproved therapy for maintaining renal function, rapidly reduces serum prolactin levels [ 59 ].
Prolactin has immunostimulatory effects, and a low prolactin level has been associated with a worse outcome in septic mice [ 60 ]. The recognition that impaired adrenal function, as assessed by a subnormal rise in plasma cortisol to synthetic adrenocorticotropic hormone, was related to poor outcomes in septic shock [ 61 ] led to a multicentre trial that revealed survival benefit from early administration of hydrocortisone 50 mg four times daily [ 62 ]. However, the debate continues surrounding its contribution to the development of critical illness neuromyopathy and delayed weaning [ 63 ]. The sick euthyroid syndrome is likewise associated with worse outcomes [ 64 ] yet several drugs that affect thyroid function, such as amiodarone, are frequently used in critically ill patients.
A trial of immunonutrition had to be prematurely terminated after an interim analysis revealed a significant mortality increase in septic patients [ 66 ]. The Canadian Department of Health recently issued a safety alert on Drotrecogin-alpha Xigris , the first licensed therapy for severe sepsis, after post-hoc analyses of trial data revealed an excess mortality in patients with single organ dysfunction who had received surgery within 30 days prior to study treatment [ 67 ].
In a recent retrospective analysis of three large trials of patients with acute coronary syndromes, Rao et al. There may be an immunological reason underlying this apparent harm. Hebert et al. It remains to be seen whether remaining blood constituents in leukocyte-depleted blood are able to also affect the immune response. A recent meta-analysis [ 70 ] comparing the use of proton pump inhibitors against either placebo or an H2-antagonist found a significant reduction in rebleeding and the need for surgical intervention.
Yet despite this clear benefit, the trend in mortality was actually in the opposite direction. For studies of intravenous therapy, as is given to critically ill patients, the odds ratio for mortality was 1. It should be immediately acknowledged that most of the above findings have been derived from relatively small patient studies or extrapolated from in vivo and in vitro laboratory studies.
As with most aspects of medicine, there are contradictory results. Yet sufficient data exist to suggest that the possibility of insidious harm should not be lightly dismissed.
The above litany of problems should also not be used as a reason to abandon current practices, but instead to stimulate discussion, refine their use, and to encourage trials designed to confirm or refute detriment. Our concern is that neither the inclination nor the funding will be generally available to revisit accepted dogma. We will thus have to rely on a slowly evolving approach, where new therapies are compared with conventional treatments, or where a media-highlighted concern propels a certain strategy into the spotlight.
This was the case, for example, with the use of albumin for fluid administration. The subsequent prospective randomised trial of 6, patients revealed no overall difference in mortality; intriguingly, subset analysis suggested benefit when used in sepsis but harm in head-injured patients [ 71 ]. Download: PPT. Table 1. Then and Now These survival rates do appear impressive, especially when one considers that they were obtained without antisepsis, antibiotics, blood transfusion, oxygen, and the other paraphernalia of modern medicine, and that the surgeons relied upon rudimentary surgical techniques performed without the assistance or comforts of sophisticated anaesthesia or mechanical ventilation.
The Poor Evidence Base for Many Interventions An important but generally overlooked consideration is the possibility that superficially attractive, short-term benefits may camouflage an underlying tendency to cause harm. Table 2. Underlying Mechanisms for Why Our Treatments May Cause Harm How can we explain, at the molecular level, the covert harm to the patient from standard drugs such as antibiotics, sedatives, and inotropes?
- Treating Critical Illness: The Importance of First Doing No Harm.
- EXPLORE Exam Practice Questions: EXPLORE Practice Tests & Review for the ACTs EXPLORE Exam?
- Browse Journal Content!
- Dr Andrew Conway Morris - Critical Care Biology.
- Shop now and earn 2 points per $1?
- Gut dysfunction in the critically ill − mechanisms and clinical implications.
Figure 1. Harm from Antibiotics The reason for this preamble is to emphasise the role of the systemic inflammatory response and the likely fundamental importance of the mitochondrion in the development of multiple organ failure, and also the mitochondrion's distant lineage but existing genetic linkage to bacteria. Harm from Other Drugs and Interventions Other drugs are known to affect hormone levels. These concerns can be replicated across virtually every therapy area in the critically ill. Mechanical ventilation. Blood transfusion. Proton pump inhibitors. Conclusions It should be immediately acknowledged that most of the above findings have been derived from relatively small patient studies or extrapolated from in vivo and in vitro laboratory studies.
References 1. Lewis M The social history of the navy — Mechanicsburg Pennsylvania : Stackpole Books. Beatty W List of wounded at Battle of Trafalgar. Accessed 22 April View Article Google Scholar 3. View Article Google Scholar 4. View Article Google Scholar 5. JAMA 61— View Article Google Scholar 7. Arias E United States life tables, Natl Vital Stat Rep View Article Google Scholar 8. Lancet — View Article Google Scholar 9. Crit Care Med — View Article Google Scholar SvO 2 Collaborative Group. N Engl J Med — Canadian Critical Care Trials Group.
The Acute Respiratory Distress Syndrome Network Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. C5a-mediated neutrophil phagocytic dysfunction is RhoA-dependent and predicts nosocomial infection in critically ill patients. Blood ; Thrombo-prophylaxis in intensive care: a nationwide, multi-disciplinary quality improvement project.
JICS ; Diagnostic importance of pulmonary interleukin-1 beta and interleukin-8 in ventilator-associated pneumonia. Thorax Recent human to poultry host jump, adaptation, and pandemic spread of Staphylococcus aureus. Conway Morris A , Howie N. Pain in medical patients: an underrecognised problem? J R Coll Physicians Edin ; —5.
C5a mediates peripheral blood neutrophil dysfunction in critically ill patients. Evaluation of diagnostic methodology on the reported incidence of ventilator-associated pneumonia. Trappin-2 promotes early clearance of Pseudomonas aeruginosa through CDdependent macrophage activation and neutrophil recruitment.
Am J Pathol ; Resuscitation ; The TIMI risk score accurately risk stratifies patients with undifferentiated chest pain presenting to an Emergency Department. Heart ; Editorials Conway Morris A. Novel diagnostic techniques in Ventilator-acquired pneumonia. Triage during pandemic influenza: seeking absolution in numbers? Br J Anaes ; Ventilator Associated Pneumonia: can we ensure that a quality indicator does not become a game of chance?
Hyperinflammation and mediators of immune suppression in critical illness.